Comparative genomics of quinolone-resistant Escherichia coli from broilers and humans in Norway

Author:

Slettemeås Jannice Schau,Sekse Camilla,Sunde Marianne,Norström Madelaine,Wester Astrid Louise,Naseer Umaer,Simonsen Gunnar Skov,Ulstad Charlotte Rosenberg,Urdahl Anne Margrete,Lagesen Karin

Abstract

Abstract Background The usage of fluoroquinolones in Norwegian livestock production is very low, including in broiler production. Historically, quinolone-resistant Escherichia coli (QREC) isolated from Norwegian production animals rarely occur. However, with the introduction of a selective screening method for QREC in the Norwegian monitoring programme for antimicrobial resistance in the veterinary sector in 2014; 89.5% of broiler caecal samples and 70.7% of broiler meat samples were positive. This triggered the concern if there could be possible links between broiler and human reservoirs of QREC. We are addressing this by characterizing genomes of QREC from humans (healthy carriers and patients) and broiler isolates (meat and caecum). Results The most frequent mechanism for quinolone resistance in both broiler and human E. coli isolates were mutations in the chromosomally located gyrA and parC genes, although plasmid mediated quinolone resistance (PMQR) was also identified. There was some relatedness of the isolates within human and broiler groups, but little between these two groups. Further, some overlap was seen for isolates with the same sequence type isolated from broiler and humans, but overall, the SNP distance was high. Conclusion Based on data from this study, QREC from broiler makes a limited contribution to the incidence of QREC in humans in Norway.

Funder

Norwegian Research Funding for Agriculture and Food Industry

Norwegian Veterinary Institute

Publisher

Springer Science and Business Media LLC

Reference85 articles.

1. Bolon MK. The newer fluoroquinolones. Med Clin North Am. 2011;95(4):793–817. viii.

2. NORM/NORM-VET. NORM/NORM-VET. 2022. Usage of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Norway. Tromsø / Oslo; 2023. Report No.: ISSN:1502–2307 (print) / 1890–9965 (electronic).

3. Norwegian Directory of Health. Antibiotics in primary care 2024 [ https://www.helsedirektoratet.no/retningslinjer/antibiotika-i-primaerhelsetjenesten

4. Norwegian Directory of Health. Antibiotics in the hospital 2024 [ https://www.helsedirektoratet.no/retningslinjer/antibiotika-i-sykehus

5. WHO. Critically important antimicrobials for human medicine, 6th revision. Licence: CC BY-NC-SA 3.0 IGO. World Health Organization; 2019.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3